tiprankstipranks
Trending News
More News >
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market

MiNK Therapeutics (INKT) Financial Statements

Compare
143 Followers

MiNK Therapeutics Financial Overview

MiNK Therapeutics's market cap is currently $33.36M. The company's EPS TTM is $-2.907; its P/E ratio is ―; MiNK Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 2.70B$ 0.00$ 0.00
Gross Profit$ 0.00$ -204.62K$ -28.24B$ -28.36B$ -55.06K
Operating Income$ 0.00$ -22.92M$ -30.95M$ -28.36M$ -14.64M
EBITDA$ 0.00$ -22.25M$ -30.83M$ -27.70M$ -13.74M
Net Income$ -10.78B$ -22.46M$ -24.78M$ -23.11M$ -15.68M
Balance Sheet
Cash & Short-Term Investments$ 4.58B$ 3.37M$ 19.64M$ 38.89M$ 2.69M
Total Assets$ 5.72M$ 4.55M$ 21.47M$ 40.24M$ 4.56M
Total Debt$ 4.92M$ 0.00$ 0.00$ 0.00$ 43.82M
Net Debt$ 347.57K$ -3.37M$ -19.64M$ -38.89M$ 41.13M
Total Liabilities$ 25.31M$ 22.61M$ 21.87M$ 16.47M$ 58.43M
Stockholders' Equity$ -19.59M$ -18.06M$ -401.30K$ 23.78M$ -53.87M
Cash Flow
Free Cash Flow$ -9.56B$ -15.84M$ -19.12M$ -13.08M$ -8.43M
Operating Cash Flow$ -9.56B$ -15.76M$ -18.87M$ -12.83M$ -8.34M
Investing Cash Flow$ 0.00$ -73.56K$ -250.05K$ -248.98K$ -95.21K
Financing Cash Flow$ 10.82B$ -407.17K$ -155.60K$ 49.26M$ 11.11M
Currency in USD

MiNK Therapeutics Earnings and Revenue History

MiNK Therapeutics Debt to Assets

MiNK Therapeutics Cash Flow

MiNK Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis